Arch Pharmalabs Limited




Country: India

Arch Pharmalabs Limited
4th Floor, H Wing, Tex Centre
Chandivli, Andheri (East)
Mumbai – 400 072
India


Contact: Raj Iyer, Ph.D.
President
Arch Pharmalabs USA Inc.


Phone: 707.938.1247
FAX: 707.938.1892
E-Mail:raj.iyer@archpharmalabs.com


http://www.archpharmalabs.com

Transforming Chemistry

Producing Success


Please click below for Niche Technologies

Arch Facilities across India

Company Profile

Pharmaceutical product development and commercialization is a highly expensive and lengthy process. Arch Pharmalabs Limited is a top-tier, India-based API player. We provide the global drug industry with a powerful competitive edge through innovative, quality-focused, timely and cost-advantaged process R&D and manufacturing solutions across branded and generic product life cycles. The Company has two state-of-the-art Process Technology centres, eleven cGMP and ISO-certified sites (including US FDA, EDQM and TGA inspected facilities) and 2,500 people in India. Maintaining a unique position as a non-competing supplier, Arch Pharmalabs' customer-centric, IP-secure service and product offering includes:

  • Process R&D, exclusive synthesis of drug intermediates and active ingredients to enable pre-clinical studies, Phase I-III clinical trials, validation / launch planning and life cycle management for global innovators.
  • Manufacture and supply of a wide range of generic APIs and intermediates for a worldwide client base.
  • Comprehensive QA & Regulatory support.

A key component of Arch Pharmalabs' growth strategy is to access superior chemical technologies to help its customers develop newer, better and value-enhanced products. Notable examples include High-Potency Drug Manufacturing and SMB Separations. With annual revenues of USD 200 million, Arch Pharmalabs has experienced robust financial growth since inception in 1999, while exceeding its customers' expectations. Arch Pharmalabs (USA) Inc. is the company's US subsidiary and spearheads strategic alliance, commercial and marketing initiatives in North America.


Product List: 117

PON:Page:


 


Active Pharmaceutical Ingredients

ACECLOFENAC
EP/BP
NSAIDs
AMLODIPINE BESYLATE
EP
Calcium channel blocker
ATORVASTATIN CALCIUM (AMORPHOUS)
In-house
Lipid lowering agent
ATORVASTATIN CALCIUM (CRYSTALLINE)
IP/In-house
Lipid lowering agent
BENZTROPINE MESYLATE*
USP
Anti cancer
BROMHEXINE HYDROCHLORIDE
EP/BP
Expectorant
BUSULFAN*
USP
Anti cancer
CAPECITABINE *
In-house
Anti cancer
CETIRIZINE DIHYDROCHLORIDE
EP/BP
Anti histaminic
CITALOPRAM HYDROBROMIDE
USP/EP/In-house
Anti depressant
CLOPIDOGREL BISULPHATE (FORM I)
USP
Anti platelet agent
CLOPIDOGREL BISULPHATE (FORM II)
USP
Anti platelet agent
DECITABINE*
In-house
Anti cancer
DICLOFENAC SODIUM
USP/EP/BP
NSAIDs
DOCETAXEL ANHYDROUS*
In-house
Anti cancer
DULOXETINE HYDROCHLORIDE
In-house
Anti depressant
EFAVIRENZ
USP (draft)
Anti retroviral
ENTACAPONE *
In-house
Anti parkinsonian
EPHEDRINE HYDROCHLORIDE
USP/EP/BP
Decongestant
EPHEDRINE SULFATE #
USP
Decongestant
ESCITALOPRAM OXALATE
In-house
Anti depressant
FEXOFENADINE HYDROCHLORIDE
USP
Anti histaminic
FLUCONAZOLE #
USP/EP
Anti fungal
GEFITINIB *
In-house
Anti cancer
GEMCITABINE HYDROCHLORIDE
USP/EP
Anti cancer
IMATINIB MESYLATE *
In-house
Anti cancer
IRINOTECAN HYDROCHLORIDE *
In-house
Anti cancer
ISRADIPINE *
USP/EP/BP
Calcium channel blocker
L -PHENYLEPHRINE *
US/EP
Decongestant
LACIDIPINE *
BP
Calcium channel blocker
LAMIVUDINE
USP
Anti retroviral
LEVOCETIRIZINE DIHYDROCHLORIDE
IP/In-house
Anti histaminic
MANIDIPINE HYDROCHLORIDE*
In-house
Calcium channel blocker
MEFENAMIC ACID
USP/EP/BP
NSAIDs
MELOXICAM
USP/EP
NSAIDs
METOCLOPRAMIDE HYDROCHLORIDE
USP/EP/BP
Anti emetic
MILNACIPRAN
In-house
Anti depressant
MONTELUKAST SODIUM
In-house
Anti asthmatic
NEVIRAPINE
USP
Anti retroviral
PACLITAXEL HYDROCHLORIDE *
USP/EP
Anti cancer
PANTOPRAZOLE SODIUM
EP/In-house
Proton pump inhibitor
PERINDOPRIL ERBUMINE
EP
ACE inhibitor
PIROXICAM
USP/EP/BP
NSAIDs
PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE *
In-house
Anti parkinsonian
PSEUDOEPHEDRINE HYDROCHLORIDE
USP/EP/BP
Decongestant
PSEUDOEPHEDRINE SULFATE #
USP
Decongestant
RABEPRAZOLE SODIUM *
In-house
Proton pump inhibitor
RITONAVIR *
USP
Anti retroviral
S (+) IBUPROFEN
In-house
NSAIDs
STAVUDINE
USP
Anti retroviral
TOPOTECAN HYDROCHLORIDE *
In-house
Anti cancer
TRANDOLAPRIL
EP
ACE inhibitor
ZIDOVUDINE
USP
Anti retroviral


Intermediate List

2-(4-BENZHYDRYL-1-PIPERAZINYL) ETHYL ACETOACETATE
CAS:89226-49-3
MF: C23H28N2O3 MW: 380.48
Manidipine
2-ETHOXY NAPHTHALENE-1-CARBONYL CHLORIDE
CAS:55150-29-3
MF: C13H11ClO2 MW: 234.68
Nafcillin
3,4-DICHLORO-A- METHOXY PHENYL ACETIC ACID CHLORIDE
CAS:83833-34-5
MF: C9H7Cl3O2 MW: 253.50
Clometocillin
3,4-DIMETHOXY-2-METHYLPYRIDINE-N-OXIDE
CAS:72830-07-0
MF:C8H11NO3 MW: 169.18
Pantoprazole
3-CHLORO-1,2-BENZISOTHIAZOLE
CAS:7716-66-7
MF: C7H4ClNS MW: 169.63
Ziprasidone
3-PIPERAZINYL-1,2-BENZISOTHIAZOLE HYDROCHLORIDE
CAS:87691-88-1, 144010-02-
MF: C11H13N3S.HCl MW: 255.76
Ziprasidone
4-(4-FLUOROBENZOYL)-3-(HYDROXY METHYL)-BENZONITRILE
CAS:260371-16-2
MF: C15H10FNO2 MW: 255.24
Citalopram
AAA; ACETO ACETANILIDE
CAS:102-01-2
MF: C10H11NO2 MW: 177.20
Pigments
AABZ5-ACETOACETYLAMINOBENZIMIDAZOL-2-ONE
CAS:26576-46-5
MF: C11H11N3O3 MW: 233.23
Pigments
AMINO CARBINOL; (S)-2-(2-AMINO-5-CHLOROPHENYL)-4-CYCLOPROPYL-1,1,1-TRIFLUORO-3-BUTYN-2-OL
CAS:209414-27-7
MF: C13H11ClF3NO
Efavirenz
ANHYDRO; 3-AZIDO-3-DEOXY-5-O-TRIPHENYL METHYL -THYMIDINE
CAS:25442-42-6
MF: C29H26N2O4
Zidovudine
AOSA; (3R,4R)-4-ACETOXY-3-[(R)-1-(TERT-BUTYL-DIMETHYLSILYLOXY)ETHYL]AZETIDIN-2-ONE
CAS:76855-69-1
MF: C13H25NO4Si
Carbapenem
AST;(S)-2-{3-[3-[2-(7-CHLORO-2-QUINOLINYL)- ETHENYL]-PHENYL]-3-HYDROXYPROPYL} BENZOIC ACID METHYL ESTER MONOHYDRATE
CAS:287930-78-3
MF: C28H24NO3Cl.H2O MW: 475.99
Montelukast
ATS-5;(R)-4-CYANO-3-HYDROXYBUTYRIC ACID ETHYL ESTER
CAS:141942-85-0
MF: C7H11NO3
Atorvastatin
ATS-8;(4R,CIS)-1,1-DIMETHYLETHYL-6-CYANO METHYL-2,2-DIMETHYL-1,3-DIOXANE-4-ACETATE
CAS:125971-94-0
MF: C14H23NO4
Atorvastatin
ATS-9;(4R,CIS)-1,1-DIMETHYLETHYL-6-AMINOETHYL-2,2-DIMETHYL-1,3-DIOXANE-4-ACETATE
CAS:125995-13-3
MF: C14H27NO4
Atorvastatin
ATV-1;TERT-BUTYL (4R,6R)-2-[[[6-(2-4-FLUORO PHENYL)-5-ISOPROPYL-3-PHENYL-4-(PHENYL CARBAMOYL)-PYRROL-1-YL]ETHYL]-2,2-DIMETHYL-1,3-DIOXAN-4-YL]ACETATE
CAS:125971-95-1
MF: C40H47FN2O5
Atorvastatin
AZIDO; 1-(4-AZIDO-5-TRITYLOXIMETHYL- TETRAHYDRO-FURAN-2-YL)-5-METHYL-1H-PYRIMIDINE-2,4-DIONE
CAS:29706-84-1
MF: C29H27N5O4 MW: 509.57
Zidovudine
BENZYL OCTAHYDROINDOLE-2-CARBOXYLATE (ABSOLUTE 2S,3AR,7AS)
CAS:144540-71-6
MF: C16H21NO2 MW: 259.30
Trandolapril
BIBEA;4-METHYL-3-OXO-N-PHENYL-2-(PHENYL METHYLENE)-PENTANAMIDE
CAS:125971-57-5
MF: C19H19NO2
Atorvastatin
CAOI; 6-CHLORO-5-(2-CHLOROACETYL)-2-OXYINDOLE
CAS:118307-04-3
MF: C10H7Cl2NO2 MW: 244.08
Ziprasidone
CEOI; 6-CHLORO-5-(2-CHLOROETHYL)-2-OXYINDOLE
CAS:118289-55-7
MF: C10H9CI2NO MW: 230.09
Ziprasidone
CLOPIDOGREL BASE;S-(2-CHLOROPHENYL)-(6,7-DIHYDRO-4H-THIENO[3,2-C]PYRIDIN-5-YL)-ACETIC ACID METHYL ESTER
CAS:113665-84-2
MF: C16H16ClNO2S
Clopidogrel
CME;[1R-[1-A-(2S*,5R*),2SS,5SS]]-5-(4-AMINO-2-OXO-1-(2H)-PYRIMIDINYL)-1,3-OXATHIOLANE-2-CARBOXYLIC ACID 5-METHYL-2-(1-METHYL- ETHYL)CYCLOHEXYL ESTER
CAS:147126-73-6
MF: C18H27N3O4S
Lamivudine
CMIC CHLORIDE;3-(2-CHLOROPHENYL)-5-METHYL ISOXAZOLE-4-CARBONYL CHLORIDE
CAS:25629-50-9
MF: C11H7Cl2NO2
Cloxacillin
COUPLED AMINE HCL;S-(+)-METHYL-2(2-THIENYLETHYLAMINO)-2-(2-CHLOROPHENYL) ACETATE HYDROCHLORIDE
CAS:141109-19-5
MF: C15H16ClNO2S.HCl
Clopidogrel
CPG-ESTER; (S)-(+)-2-CHLOROPHENYLGLYCINE METHYL ESTER TARTRATE SALT
MF: C13H16ClNO8 MW: 349.72
Clopidogrel
DCMIC CHLORIDE;3-(2,6 DICHLOROPHENYL)-5-METHYL ISOXAZOLE-4-CARBONYL CHLORIDE
CAS:4462-55-9
MF: C11H6Cl3NO2
Dicloxacillin
DIOL BASE; 4-[4-(DIMETHYLAMINO)-1-(4-FLUORO- PHENYL) -1-HYDROXYBUTYL]-3-(HYDROXY -METHYL)BENZONITRILE
CAS:103146-25-4
MF: C20H23FN2O2 MW: 342.40
Citalopram
DIOL;(S)-1-[[[1-[3-[2-(7-CHLORO-2-QUINOLINYL)- ETHENYL]PHENYL]]-3-[2-(1-HYDROXY-1-METHYLETHYL) PHENYL]PROPYL-1-OL]]
CAS:142569-70-8
MF: C29H28ClNO2 MW: 457.99
Montelukast
DKT-3;4-FLUORO-A-(2-METHYL-1-OXOPROPYL)-?-OXO-N,SS-DIPHENYL BENZENE BUTANAMIDE
CAS:125971-96-2
MF: C26H24FNO3
Atorvastatin
DMA; S (+)-3-(DIMETHYLAMINO)-1-(THIOPHEN-2-YL)PROPAN-1-OL
CAS:132335-44-5
MF: C9H15NOS
Duloxetine
DMAT; 3-(DIMETHYLAMINO)-1-(THIOPHEN-2-YL)-PROPAN-1-ONE HYDROCHLORIDE
CAS:5424-47-5
MF: C9H13NOS.HCl MW: 219.73
Duloxetine
DMN; S (+) - N,N-DIMETHYL-3-(NAPHTHALEN-1-YLOXY)-3-(THIOPHEN-2-YL) PROPAN-1-AMINE (BASE, OXALATE AND PHOSPHATE SALT)
CAS:132335-47-8 (Oxalate)132335-46-7 (Base)
MF: C19H21NOS MW:311.44
Duloxetine
E4CAA; ETHYL 4-CHLORO ACETOACETATE
CAS:638-07-3
MF:C6H9ClO3 MW: 164.59
Amlodipine Atorvastatin
EDPCC;4-ETHYL-2,3-DIOXO-PIPERAZINE CARBONYL CHLORIDE
CAS:59703-00-3
MF: C7H9ClN2O3
Piperacillin
EPCP;(R)-[[(4-ETHYL-2,3-DIOXOPIPERAZIN-1-YL) CARBONYL]AMINO]PHENYLACETIC ACID
CAS:63422-71-9
MF: C15H17N3O5
Piperacillin
FCMIC CHLORIDE;3-(2-CHLORO-6-FLUOROPHENYL)-5-METHYL ISOXAZOLE-4-CARBONYL CHLORIDE
CAS:69399-79-7
MF:C11H6Cl2FNO2
Flucloxacillin
FEN-1; 4- [4- [4- (HYDROXYDIPHENYLMETHYL)- 1- PIPERIDINYL]- 1- OXOBUTYL]- A,A- DIMETHYL BENZENEACETIC ACID METHYL ESTER
MF: C33H39NO4 MW: 513.67
Fexofenadine
FEXO-8; 4- [4- [4- (HYDROXYDIPHENYLMETHYL)- 1- PIPERIDINYL]- 1- OXOBUTYL]- A,A- DIMETHYL BENZENEACETIC ACID
CAS:76811-98-8
MF:C32H37NO4 MW:499.64
Fexofenadine
GBI; 1,1-CYCLOHEXANEDIACETIC ACID MONO METHYLESTER
CAS:60142-94-1
MF:C11H18O4 MW: 214.26
Gabapentin
H-PHE(4-NO2)-OET·HCL; ETHYL (2S)-2-AMINO-3-(4-NITROPHENYL)- PROPANOATE HYDROCHLORIDE
CAS:58816-66-3
MF: C11H14N2O4.HCl MW: 274.70
HEEP BASE; 1-[2-(2-HYDROXYETHOXY)ETHYL]PIPERAZINE
CAS:13349-82-1
MF: C8H18N2O2
Quetiapine
HMMP; 2-HYDROXYMETHYL-3-METHYL-4-(3-METHOXYPROPOXY)PYRIDINE
MF:C11H17NO3 MW: 211.26
Rabeprazole
HOPO; 2-HYDROXYPYRIDINE-1-OXIDE
CAS:13161-30-3
MF: C5H5NO2 MW: 111.10
Coupling reagent for amide formation
LAMIVUDINE SALICYLATE; (2R,CIS)-4-AMINO-1-[2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]-2-(1H)-PYRIMIDIN-ONE 2-HYDROXYBENZOATE
CAS:173522-96-8
MF: C8H11N3O3S.C7H6O3 MW: 380.48
Lamivudine
MMA; S (+)-3-(METHYLAMINO)-1-(THIOPHEN-2-YL)PROPAN-1-OL
CAS:116539-55-0
MF: C8H13NOS
Duloxetine
MMAA; MONOMETHYL ACETOACETAMIDE
CAS:20306-75-6
MF: C5H9NO2 MW: 115.13
Agrochemical
MONTELUKAST ACID; 1-[[[(1R)-1-[3-[(1E)-2-(7-CHLORO-2-QUINOLINYL)ETHENYL] PHENYL]-3-[2-(1-HYDROXY-1-METHYLETHYL) PHENYL]PROPYL] THIO]METHYL]CYCLOPROPANEACETIC ACID
CAS:158966-92-8
MF: C35H36ClNO3S MW: 586.18
Montelukast
MONTELUKAST DCHA SALT;1-[[[(1R)-1-[3-[(1E)-2-(7-CHLORO-2-QUINOLINYL)ETHENYL] PHENYL]-3-[2-(1-HYDROXY-1-METHYLETHYL) PHENYL]PROPYL] THIO]METHYL]CYCLOPROPANEACETIC ACID N-CYCLOHEXYLCYCLOHEXANAMINE SALT
CAS:577953-88-9
MF: C35H36ClNO3S. C12H23N MW: 767.60
Montelukast
N-(4-CYANO-3-TRIFUOROMETHYLPHENYL)-METHACRYLAMIDE
CAS:90357-53-2
MF: C12H9F3N2O MW: =254.21
Bicalutamide
N-BENZYL-4-PIPERAZINECARBOXYALDEHYDE
CAS:22065-85-6
MF:C13H17NO MW: 203.28
Donepezil
NFHDA; N-FORMYL HEXAMETHYLENIMINE DIMETHYL ACETAL
CAS:32895-16-2
MF:C9H19NO2 MW: 173.25
MecillinamPivmecillinam
OCTAHYDROINDOL-2-CARBOXYLIC ACID (RACEMATE 2R,3AS,7AR)
CAS:87679-58-1
MF: C9H15NO2 MW: 169.2236
Trandolapril
PANTO CHLORO SULFIDE; 5-(DIFLUROMETHOXY)-2-[(3-METHOXY-4-CHLORO-2- PYRIDINYL)METHYLMERCAPTO]- 1H-BENZIMIDAZOLE
CAS:368890-20-4
MF: C15H12ClF2N3O2S MW:371.80
Pantoprazole
PANTO CHLORO; 2-CHLOROMETHYL-3,4-DIMETHOXYPYRIDINE HYDROCHLORIDE
CAS:72830-09-2
MF: C8H11Cl2NO2 MW: 224.08
Pantoprazole
PANTO SULFIDE; 5-(DIFLUROMETHOXY)-2-[(3,4-DIMETHOXY- 2- PYRIDINYL)METHYLMERCAPTO]-1H-BENZIMIDAZOLE
CAS:102625-64-9
MF: C16H15F2N3O3S MW: 367.37
Pantoprazole
PCBP; 1-(4-CHLOROBENZHYDRYL)PIPERAZINE
CAS:303-26-4
MF: C17H19ClN2 MW: 286.80
Cetirizine
PHTHALOYL AMLODIPINE;3-ETHYL-5-METHYL-4-(2-CHLOROPHENYL)-2-(2-PHTHALIMIDOETHOXY)-METHYL-6-METHYL-1,4-DIHYDROPYRIDINE-3,5-DICARBOXYLATE
CAS:88150-62-3
MF: C28H27ClN2O7 MW: 538.98
Amlodipine
PMIC CHLORIDE;3-PHENYL-5-METHYL ISOXAZOLE-4-CARBONYL CHLORIDE
CAS:16883-16-2
MF: C11H8ClNO2
Oxacillin
RABE SULFIDE; 2-[[4-(3-METHOXYPROPOXY)-3-METHYL -PYRIDINE-2-YL]METHYLTHIO]-1H-BENZIMIDAZOLE
CAS:117977-21-6
MF: C18H21N3O2S MW: 343.44
Rabeprazole
RX5*;2-AZA-BICYCLO-[3.3.0]-OCTANE-3-CARBOXYLIC ACID BENZYL ESTER HYDROCHLORIDE (RACEMATE)
CAS:93779-29-4
MF: C15H19NO2.HCl MW: 281.7823
Ramipril
RX7 *;(S,S,S)-2-AZA-BICYCLO-[3.3.0]-OCTANE-3-CARBOXYLIC ACID BENZYL ESTER HYDROCHLORIDE
CAS:93779-31-8
MF: C15H19NO2.HCl MW: 281.7823
Ramipril
XL-2;2-DEOXY-2,2-DIFLOURO-D-ERYTHRO-PENTAFURANOSE-1-ULOSE-3,5-DIBENZOATE
CAS:122111-01-7
MF: C19H14F2O6
Gemcitabine